In fact, as the Washington Post reports, cannabis confiscations at the southern border have stumbled to the lowest point in over a decade — to only 1.5 million pounds. That’s down from a peak of four million pounds in 2009. [Read More]
If upcoming study results are positive, people with multiple sclerosis may have a marijuana gum available for treatment of symptoms by 2017. The gum is made by AXIM Biotechnology, Inc. and is called MedChew Rx.
The marijuana gum has been tested for treatment of pain and spasticity in multiple sclerosis, and the company expects the Food and Drug Administration and the European Medicines Agency to approve the product for this use. MedChew Rx contains 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC) and will be available by prescription.
Cannabidiol is one of more than 100 cannabinoid chemicals found in marijuana plants. It does not make people high and has been shown to possess multiple health benefits, including an ability to treat seizures and other neurological conditions. THC, another type of cannabinoid, has psychoactive properties as well as medicinal abilities.
Unlike other states that have passed medical marijuana legislation, New York prohibits marijuana for smoking. Instead, it allows the drug to be sold in liquid or in oil form, for use in vaporizers, or in capsules that can be taken orally. The program is only for patients with very serious or terminal illnesses, including cancer, HIV or AIDS, amyotrophic lateral sclerosis (ALS), and Parkinson’s disease. New York is also limiting the number of dispensaries to 20–far fewer than the hundreds in states such as California and Colorado.
Critics say that the small number of dispensaries will restrict patient access to the drug and that New York has gone too far in limiting the types of patients allowed in the program, while state officials say the more restrictive approach will ensure that it remains a medical, and not commercial, market.
Leafly'sCannabis 101 breaks down some important visual cues to look for when purchasing cannabis. Quality standards may vary depending on you location and access to cannabis and there are many other attributes to consider when buying cannabis. Besides the appearance the smell, effects, price, and quantity available may also influence your choice when selecting a strain. Potent cannabis doesn't necessarily mean it's high quality if it's missing the flavors or effects that you are looking for. Test data can also go a long way towards understanding what to expect from the cannabis you chose.
Hugh Hempel is a technology industry veteran turned health care entrepreneur. In this moving talk he discusses how medicinal cannabis has enriched the lives of his ailing 11 year-old daughters. This talk will challenge your views of medical marijuana.
Hugh Hempel is a technology industry veteran turned healthcare entrepreneur. During his 30-year career in high technology, Hugh has held numerous senior management positions in many innovative and pioneering technology companies.
As chief operating officer and co-founder of Hopelink, Hugh launched one of the first Healthcare Internet start-ups that matched cancer patients with online clinical trials. Prior to founding Hopelink, Hugh held a variety of positions at Netscape, the first successful consumer Web browser software company. As Director of Online Marketing and Director of Enterprise Sales and Marketing, Hugh worked with the team that helped make the Web a reality for millions of people worldwide.
Prior to joining Netscape, Hugh worked as Manager of Engineering and Science markets for Apple Computer. While at Apple, he helped define the Apple Newton Messagepad, Apple’s first handheld computer that was a revolution in personal computing.
Hugh also held the position of Director at Computervision, an early pioneer in Computer Aided Design and Manufacturing (CAD/CAM) software used by companies around the world to develop automotive and aerospace products. Hugh’s first job in the technology industry was as a National Accounts Representative for IBM after graduating with a B.S. in Engineering Management from the University of Vermont.
In 2006, Hugh’s 10 year old identical twin daughters were diagnosed with a rare and fatal neurodegenerative disease called Niemann Pick Type C, often referred to as “Childhood Alzheimer’s.” Since that time, Hugh and his wife Chris have immersed themselves in science and medicine and discovered through their own research that a simple sugar compound called cyclodextrin could save their twins’ lives. As parents, they successfully filed applications with U.S. Food and Drug Administration (FDA) and received permission to try this never before used treatment on their daughters.
The Hempel’s journey to develop cyclodextrin has made international headlines and was recently featured in The Wall Street Journal in a 10 chapter story entitled, “A Desperate Fight to Save Kids and Change Science,” as well as in a documentary called “Here. Us. Now.” More information can be found at http://projects.wsj.com/trials and http://here-us-now.com/.
In 2009, Hugh and his wife Chris became interested in Cannabidiol (CBD), one of at least 80 active cannabinoids identified in marijuana and hemp, as his twins suffer from intractable seizures as a result of their disease and experience up to a 100 seizures a week. Through extensive research, they learned that cannabinoid receptors are involved in a vast array of functions in the body, including helping to control brain and nerve activity (including memory and pain), energy metabolism, heart function, and the immune system. After realizing pharmaceutical grade cannabis products were unavailable for their daughters and other patients in Nevada, the Hempel’s decided to create a Nevada based “cannabusiness” focused on legally developing and distributing high-quality flowers, extracts and concentrates at competitive prices.
Hugh sits on the Board of Directors for The Global Genes Project, a leading rare and genetic disease non-profit advocacy organization based in California. He is a frequent speaker on a variety of healthcare topics including small clinical trial design, new drug discovery, and patient reported outcome systems for more efficient clinical research.
Hugh aims to create a large scale cannabis clinical research clearing house in an effort to better elucidate the potential benefits of this cannabis plant. Until such time as there are readily available quality cannabis medicinal products on the market, this goal is nearly impossible. The creation of a pharmaceutical quality cannabis supply network is the first step towards this larger goal of building knowledge about using cannabis to improve health.
Upscale TV makes its debut by interviewing two goliaths in the medical cannabis industry. Steve DeAngelo, Founder of Harborside Health Center - CoFounder of The ArcView Group - and globally recognized cannabis activist, discusses what it was like when he first entered the industry years ago all the way up to present day. Dale Sky Jones, Executive Chancellor of Oaksterdam University and cannabis policy expert then walks us through what you should expect out of 2016 cannabis legalization legislation. Additionally, she breaks down why it is important for YOU to pay attention to what you are voting for, rather than passing a bill just to pass it. To go along with two great interviews, we hit the streets to talk to people in Downtown San Diego so that we can find out exactly what they think of DEA Cheif Chuck Rosenberg's dumb comments about the medical cannabis industry. Also, with cannabis investing being one of the hottest topics around the industry, we take a minute to talk about the ups and downs of 2015's cannabis stock market, while also giving you a small preview to what you can expect in 2016. [ Source ]
Abdullah from Bong Appetite travels to the hippie mecca of Northern California to check out the OM Collective—an all-women grow and the makers of OM Edibles cannabis-infused topicals, tinctures, and edibles. Owner Maya Elisabeth shows Abdullah how to make a few varieties ofcannabis olive oils infused with garlic and ginger to use in an upcoming feast with their friends from The Cookie Fam. In a beautiful setting overlooking the San Francisco Bay, Chef Tim Milojevich prepares a mouth-watering meal of Peruvian ceviche, hearts-of-palm salad, sea bass baked in banana leaves, and prime rib with chimichurri sauce, all prepared with Maya’s infused olive oils. Don’t judge Abdullah ... We bet you wouldn’t be able to keep your clothes on after this meal, either. [Source]
Weed is pretty renowned for making you want to eat all food in sight, but this new study claims that cannabis can actually tackle the obesity epidemic. Wait, what?
Health experts in the U.S. have analyzed 12 years worth of data to find that legalizing the drug encouraged a significant number of people to lose weight. In the states which decriminalized cannabis under the medical marijuana legislation, levels of obesity dropped by between two to six per cent, researchers from Cornell and San Diego University found.
This surprising trend apparently occurred because the law encouraged some young people to smoke up instead of drinking a shit ton of calorific alcohol. As well as encouraging teens to ditch the far more dangerous booze, cannabis also helped more elderly resident get more active, by cutting back on their chronic pain. [Source]
Green Medicine is a new documentary film that gives an insight into the medical cannabis scene in Chile. It follows the story of Daya Foundation, a non-profit organization, that was granted a license by the Chilean government to begin Latin America's first legal cannabis grow in 2014.
Enedina Stangerappeared at the local sheriff’s complex on Monday for processing after pleading guilty earlier this month to a drug possession charge — a reduction from her original charge of felony child endangerment. She was sentenced instead to six months probation and mandatory parenting classes.
Stanger, along with her husband Michael and their children, subsequently moved to Colorado, where use of the drug is legal. She suffers from a condition called Ehlers-Danlos syndrome, which generates spasms in her joints, and uses a wheelchair. [Source]
Medical marijuana farmer Tom Lauerman has dedicated his life to normalizing cannabis in the U.S. He went from being arrested at his medical collective in 1999, to working with the federal government today to establish the first ever national safety guidelines for the cannabis industry. [Source]
By juicing cannabis, patients receive most of the medical benefits of the plant without the “high”. Cannabis in its raw form is still psychoactive, just not like the medicating effects patients are used to from smoking or eating an edible. [Source]
Think big and then chase your dream passionately. Jahan Peston, founder of BOHEMCO, a company that plans to use Cannabis for various commercial uses speaks about how he and his six friends decided to build this business. He introduces the audience to the many facets of a single commodity, cannabis in this case. His talk revolves around how perspective defines the order. A chaos may be order for some but may be a troublesome puzzle for others. To decide is one's choice.
Originally of Australian descent, Jahan leads the strategy and collaborations function at Bombay Hemp Company (BOHECO) by identifying viable stakeholders in the hemp ecosystem that share BOHECO’s vision and develop strategic partnerships and collaborations to exponentially scale impact. He is also the focal point of BOHECO’s communications. Before co-founding BOHECO, Jahan helped set up start- up companies and social enterprises such as one of Mumbai’s first walking tour companies-having conducted tours for over 5000 people in 4 years. These have enabled him to bring intriguing insights on successful scaling of early stage businesses. As such, Jahan also plays an important role in developing growth strategies and raising capital for BOHECO.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. [Source]
Cristina has studied the effect of cannabinoids on lipid and carbohydrate intermediate metabolism first and on cancer cell proliferation later. She obtained her PhD with Honors in Biochemistry and Molecular Biology at Complutense University in 2000. During her postdoc at Dr. Piomelli’s laboratory (University of California Irvine, 2000-2003) she studied the involvement of another group of bioactive lipids (lysophosphatidic acid and related compounds) on pain initiation.[Source]